2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍

2021-07-10 Eur Child Adolesc Psychiatry.2021 Jul 10.

2021年7月,欧洲抽动-秽语综合征研究学会(ESSTS)发布了抽动秽语综合征和其他抽动障碍指南,本文主要总结了抽动秽语综合征和其他抽动障碍的评估和治疗最新进展,并提供了更新的决策流程,为抽动秽语综合

中文标题:

2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍

英文标题:

European clinical guidelines for Tourette syndrome and other tic disorders: summary statement

发布机构:

发布日期:

2021-07-10

简要介绍:

2021年7月,欧洲抽动-秽语综合征研究学会(ESSTS)发布了抽动秽语综合征和其他抽动障碍指南,本文主要总结了抽动秽语综合征和其他抽动障碍的评估和治疗最新进展,并提供了更新的决策流程,为抽动秽语综合征和其他抽动障碍患者的管理提供了实用的指导方法。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8a5e11c00213a980, title=2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍, enTitle=European clinical guidelines for Tourette syndrome and other tic disorders: summary statement, guiderFrom=Eur Child Adolesc Psychiatry.2021 Jul 10., authorId=0, author=, summary=2021年7月,欧洲抽动-秽语综合征研究学会(ESSTS)发布了抽动秽语综合征和其他抽动障碍指南,本文主要总结了抽动秽语综合征和其他抽动障碍的评估和治疗最新进展,并提供了更新的决策流程,为抽动秽语综合, cover=https://img.medsci.cn/2021724/1627127163553_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Jul 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年7月,欧洲抽动-秽语综合征研究学会(ESSTS)发布了抽动秽语综合征和其他抽动障碍指南,本文主要总结了抽动秽语综合征和其他抽动障碍的评估和治疗最新进展,并提供了更新的决策流程,为抽动秽语综合征和其他抽动障碍患者的管理提供了实用的指导方法。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=18393, tagName=抽动秽语综合征)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=18393, guiderKeyword=抽动秽语综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6904, appHits=151, showAppHits=0, pcHits=697, showPcHits=6753, likes=2, shares=8, comments=6, approvalStatus=1, publishedTime=Sat Jul 24 21:37:57 CST 2021, publishedTimeString=2021-07-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 24 19:46:17 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Wed Jan 03 11:28:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍.pdf)])
2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1182878, encodeId=68e911828e8fe, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eba63819496, createdName=136f05b3m21暂无昵称, createdTime=Mon Jan 10 16:15:28 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055521, encodeId=c993105552171, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c45517085, createdName=ms4000000927224850, createdTime=Mon Sep 27 22:51:39 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012408, encodeId=7cd11012408ad, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:52:10 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006891, encodeId=6cf61006891a8, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:21:56 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002442, encodeId=46241002442e2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/fbcb8986f0064135bed329ef7fca6925/b39b4776c8524194907869b4d3ff5901.jpg, createdBy=3f4d5546249, createdName=惠希彩, createdTime=Sun Jul 25 08:24:08 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2022-01-10 136f05b3m21暂无昵称

    有中文版吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1182878, encodeId=68e911828e8fe, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eba63819496, createdName=136f05b3m21暂无昵称, createdTime=Mon Jan 10 16:15:28 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055521, encodeId=c993105552171, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c45517085, createdName=ms4000000927224850, createdTime=Mon Sep 27 22:51:39 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012408, encodeId=7cd11012408ad, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:52:10 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006891, encodeId=6cf61006891a8, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:21:56 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002442, encodeId=46241002442e2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/fbcb8986f0064135bed329ef7fca6925/b39b4776c8524194907869b4d3ff5901.jpg, createdBy=3f4d5546249, createdName=惠希彩, createdTime=Sun Jul 25 08:24:08 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-09-27 ms4000000927224850

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1182878, encodeId=68e911828e8fe, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eba63819496, createdName=136f05b3m21暂无昵称, createdTime=Mon Jan 10 16:15:28 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055521, encodeId=c993105552171, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c45517085, createdName=ms4000000927224850, createdTime=Mon Sep 27 22:51:39 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012408, encodeId=7cd11012408ad, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:52:10 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006891, encodeId=6cf61006891a8, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:21:56 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002442, encodeId=46241002442e2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/fbcb8986f0064135bed329ef7fca6925/b39b4776c8524194907869b4d3ff5901.jpg, createdBy=3f4d5546249, createdName=惠希彩, createdTime=Sun Jul 25 08:24:08 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-08-28 lotus蓉
  4. [GetPortalCommentsPageByObjectIdResponse(id=1182878, encodeId=68e911828e8fe, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eba63819496, createdName=136f05b3m21暂无昵称, createdTime=Mon Jan 10 16:15:28 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055521, encodeId=c993105552171, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c45517085, createdName=ms4000000927224850, createdTime=Mon Sep 27 22:51:39 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012408, encodeId=7cd11012408ad, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:52:10 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006891, encodeId=6cf61006891a8, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:21:56 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002442, encodeId=46241002442e2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/fbcb8986f0064135bed329ef7fca6925/b39b4776c8524194907869b4d3ff5901.jpg, createdBy=3f4d5546249, createdName=惠希彩, createdTime=Sun Jul 25 08:24:08 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-08-11

    收益很大

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1182878, encodeId=68e911828e8fe, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eba63819496, createdName=136f05b3m21暂无昵称, createdTime=Mon Jan 10 16:15:28 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055521, encodeId=c993105552171, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c45517085, createdName=ms4000000927224850, createdTime=Mon Sep 27 22:51:39 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012408, encodeId=7cd11012408ad, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:52:10 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006891, encodeId=6cf61006891a8, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:21:56 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002442, encodeId=46241002442e2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/fbcb8986f0064135bed329ef7fca6925/b39b4776c8524194907869b4d3ff5901.jpg, createdBy=3f4d5546249, createdName=惠希彩, createdTime=Sun Jul 25 08:24:08 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-07-25 惠希彩

    学习学习

    0

拓展阅读

2019 AAN实践指南建议:抽动秽语综合征和慢性抽动障碍抽动的治疗

美国神经病学学会(AAN,American Academy of Neurology) · 2019-05-07

2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍—第2版(第Ⅳ部分:深部脑刺激)

欧洲抽动-秽语综合征研究学会(ESSTS,European Society for the Study of Tourette syndrome) · 2021-10-04

2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍—第2版(第Ⅰ部分:评估)

欧洲抽动-秽语综合征研究学会(ESSTS,European Society for the Study of Tourette syndrome) · 2021-10-18

2021 ESSTS临床指南:抽动秽语综合征和其他抽动障碍—第2版(第III部分:药物治疗)

欧洲抽动-秽语综合征研究学会(ESSTS,European Society for the Study of Tourette syndrome) · 2021-11-10